Web Results


As of 2014, the American Brain Tumor Association states that the prognosis for stage four brain cancer is a survival rate of approximately 14.6 months. Stage four brain cancer consists of malignant tumors called glioblastomas. The American Cancer Society states that as of 2014, the mortality rate is


The American Cancer Society lists the 5-year survival rate for stage IV non-small-cell lung cancer as about one percent; stage IV small-cell lung cancer 5-year survival rates are at two percent. Mesothelioma has a 5-year survival rate of five to ten percent.


According to the American Cancer Society, the observed 5-year survival rate for patients who are diagnosed with stage II lung cancer is around 30 percent. Depending on the location and other qualities of the primary tumor, stage II lung cancer can be divided between types IIA and IIB. Survival rates


Around 30 percent of patients diagnosed with lung cancer have already reached stage 3, and their prognosis varies according to multiple factors, according to Dr. Lynne Eldridge, writing for About.com. The median survival time for stage 3a non-small cell cancer is 15 months, and stage 3b patients hav


As of 2015, a stage 4 lymphoma cancer patient is likely to have a five-year-survival rate, states the American Cancer Society. Doctors use the number of years that surviving patients lived following treatment to determine the survival rate. If the condition of the patients improved after treatment,


Stage three pancreatic exocrine cancer has a 3 percent, five-year survival prognosis, while stage three pancreatic neuroendocrine tumors treated with surgery have a 41 percent, five-year survival prognosis, reports the American Cancer Society. Pancreatic neuroendocrine tumors that cannot be surgical


Medical professionals consider the prognosis for early stage prostate cancer very good, with a relative 5-year survival rate of 100 percent, as of 2015, states the American Cancer Society. Additionally, regional stage prostate cancer also has a survival rate of 100 percent.


The prognosis for stage III liver cancer depends on whether the cancer is localized or regional, according to the American Cancer Society. Localized liver cancers have a 28 percent five-year survival rate, while regional cancers have a 7 percent survival rate five years after the cancer is diagnosed


The prognosis for stage 3 renal cell, or kidney, cancer is a 53 percent survival rate five years after diagnosis, according to the American Cancer Society. Many factors affect the survival rate, including other health conditions the patient has and how well the cancer responds to treatment.


Cancer survival prognoses vary depending on at which stage of kidney cancer a person is diagnosed, according to the American Cancer Society. The course kidney cancer takes differs by individual cases and treatments, but observational data provide a guideline for prognoses.